Literature DB >> 2446563

Leprosy and the leprosy bacillus: recent developments in characterization of antigens and immunology of the disease.

H Gaylord1, P J Brennan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2446563     DOI： 10.1146/annurev.mi.41.100187.003241

Source DB:  PubMed          Journal:  Annu Rev Microbiol        ISSN： 0066-4227            Impact factor:   15.500


× No keyword cloud information.
  20 in total

1.  The immunomodulatory lipoglycans, lipoarabinomannan and lipomannan, are exposed at the mycobacterial cell surface.

Authors:  Sylvain Pitarque; Gérald Larrouy-Maumus; Bruno Payré; Mary Jackson; Germain Puzo; Jérôme Nigou
Journal:  Tuberculosis (Edinb)       Date:  2008-06-09       Impact factor: 3.131

2.  Specificity of IgG subclass antibodies in different clinical manifestations of leprosy.

Authors:  S Dhandayuthapani; S Izumi; D Anandan; V N Bhatia
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

3.  Detection of Mycobacterium leprae infection by PCR.

Authors:  J Wichitwechkarn; S Karnjan; S Shuntawuttisettee; C Sornprasit; K Kampirapap; S Peerapakorn
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

4.  Novel gelatin particle agglutination test for serodiagnosis of leprosy in the field.

Authors:  S Izumi; T Fujiwara; M Ikeda; Y Nishimura; K Sugiyama; K Kawatsu
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

5.  Mapping and identification of the major cell wall-associated components of Mycobacterium leprae.

Authors:  M A Marques; S Chitale; P J Brennan; M C Pessolani
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

6.  A major immunogenic 36,000-molecular-weight antigen from Mycobacterium leprae contains an immunoreactive region of proline-rich repeats.

Authors:  J E Thole; L F Stabel; M E Suykerbuyk; M Y De Wit; P R Klatser; A H Kolk; R A Hartskeerl
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

Review 7.  New immunosuppressive drugs: mechanistic insights and potential therapeutic advances.

Authors:  A W Thomson; T E Starzl
Journal:  Immunol Rev       Date:  1993-12       Impact factor: 12.988

Review 8.  Mannose-capped lipoarabinomannan in Mycobacterium tuberculosis pathogenesis.

Authors:  Joanne Turner; Jordi B Torrelles
Journal:  Pathog Dis       Date:  2018-06-01       Impact factor: 3.166

9.  Mycobacteria and human autoimmune disease: direct evidence of cross-reactivity between human lactoferrin and the 65-kilodalton protein of tubercle and leprosy bacilli.

Authors:  N Esaguy; A P Aguas; J D van Embden; M T Silva
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

10.  Specific inhibition of mRNA accumulation for lymphokines in human T cell line Jurkat by mycobacterial lipoarabinomannan antigen.

Authors:  C S Chujor; B Kuhn; B Schwerer; H Bernheimer; W R Levis; D Bevec
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.